vs
Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $56.4M, roughly 1.3× KINGSTONE COMPANIES, INC.). On growth, KINGSTONE COMPANIES, INC. posted the faster year-over-year revenue change (34.0% vs 27.7%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 25.6%).
Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
KINS vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.4M | $75.5M |
| Net Profit | $14.8M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 32.7% | 22.7% |
| Net Margin | 26.2% | — |
| Revenue YoY | 34.0% | 27.7% |
| Net Profit YoY | 171.4% | — |
| EPS (diluted) | $1.09 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.4M | $75.5M | ||
| Q3 25 | $55.7M | $54.5M | ||
| Q2 25 | $52.3M | $52.4M | ||
| Q1 25 | $50.5M | $46.0M | ||
| Q4 24 | $42.1M | $59.1M | ||
| Q3 24 | $40.8M | $80.5M | ||
| Q2 24 | $36.5M | $47.1M | ||
| Q1 24 | $35.8M | $43.8M |
| Q4 25 | $14.8M | — | ||
| Q3 25 | $10.9M | $8.8M | ||
| Q2 25 | $11.3M | $5.9M | ||
| Q1 25 | $3.9M | $3.0M | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $7.0M | $20.3M | ||
| Q2 24 | $4.5M | $-4.5M | ||
| Q1 24 | $1.4M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 32.7% | 22.7% | ||
| Q3 25 | 24.6% | 17.6% | ||
| Q2 25 | 27.1% | 12.7% | ||
| Q1 25 | 9.3% | 8.7% | ||
| Q4 24 | 15.9% | 22.6% | ||
| Q3 24 | 22.3% | 27.4% | ||
| Q2 24 | 15.7% | -4.6% | ||
| Q1 24 | 5.0% | -5.3% |
| Q4 25 | 26.2% | — | ||
| Q3 25 | 19.5% | 16.2% | ||
| Q2 25 | 21.5% | 11.2% | ||
| Q1 25 | 7.7% | 6.5% | ||
| Q4 24 | 12.9% | — | ||
| Q3 24 | 17.1% | 25.2% | ||
| Q2 24 | 12.4% | -9.6% | ||
| Q1 24 | 4.0% | -11.0% |
| Q4 25 | $1.09 | $0.26 | ||
| Q3 25 | $0.74 | $0.17 | ||
| Q2 25 | $0.78 | $0.12 | ||
| Q1 25 | $0.27 | $0.06 | ||
| Q4 24 | $0.44 | $0.40 | ||
| Q3 24 | $0.55 | $0.41 | ||
| Q2 24 | $0.37 | $-0.09 | ||
| Q1 24 | $0.12 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $4.4M | $22.7M |
| Stockholders' EquityBook value | $122.7M | $130.3M |
| Total Assets | $453.4M | $216.3M |
| Debt / EquityLower = less leverage | 0.04× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $4.4M | $22.7M | ||
| Q3 25 | $4.8M | $34.0M | ||
| Q2 25 | $5.1M | $45.3M | ||
| Q1 25 | $5.4M | $56.7M | ||
| Q4 24 | $11.2M | $68.0M | ||
| Q3 24 | $17.3M | $79.3M | ||
| Q2 24 | $25.3M | $90.7M | ||
| Q1 24 | $25.3M | $102.0M |
| Q4 25 | $122.7M | $130.3M | ||
| Q3 25 | $107.7M | $115.3M | ||
| Q2 25 | $94.9M | $104.7M | ||
| Q1 25 | $82.2M | $97.1M | ||
| Q4 24 | $66.7M | $92.1M | ||
| Q3 24 | $59.7M | $71.1M | ||
| Q2 24 | $40.8M | $48.5M | ||
| Q1 24 | $35.7M | $51.0M |
| Q4 25 | $453.4M | $216.3M | ||
| Q3 25 | $428.6M | $202.9M | ||
| Q2 25 | $393.4M | $194.9M | ||
| Q1 25 | $385.4M | $196.2M | ||
| Q4 24 | $374.9M | $213.3M | ||
| Q3 24 | $347.0M | $220.7M | ||
| Q2 24 | $319.8M | $205.0M | ||
| Q1 24 | $318.3M | $214.1M |
| Q4 25 | 0.04× | 0.17× | ||
| Q3 25 | 0.04× | 0.30× | ||
| Q2 25 | 0.05× | 0.43× | ||
| Q1 25 | 0.07× | 0.58× | ||
| Q4 24 | 0.17× | 0.74× | ||
| Q3 24 | 0.29× | 1.12× | ||
| Q2 24 | 0.62× | 1.87× | ||
| Q1 24 | 0.71× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.9M | $14.4M |
| Free Cash FlowOCF − Capex | $73.1M | $14.4M |
| FCF MarginFCF / Revenue | 129.5% | 19.1% |
| Capex IntensityCapex / Revenue | 5.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 5.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $124.0M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.9M | $14.4M | ||
| Q3 25 | $25.9M | $9.7M | ||
| Q2 25 | $9.3M | $14.1M | ||
| Q1 25 | $17.9M | $3.6M | ||
| Q4 24 | $57.9M | $15.6M | ||
| Q3 24 | $21.7M | $11.0M | ||
| Q2 24 | $7.1M | $1.0M | ||
| Q1 24 | $6.1M | $11.2M |
| Q4 25 | $73.1M | $14.4M | ||
| Q3 25 | $25.3M | $9.7M | ||
| Q2 25 | $8.7M | $14.1M | ||
| Q1 25 | $17.0M | $3.6M | ||
| Q4 24 | $55.6M | $15.6M | ||
| Q3 24 | $21.0M | $11.0M | ||
| Q2 24 | $6.6M | $1.0M | ||
| Q1 24 | $5.6M | — |
| Q4 25 | 129.5% | 19.1% | ||
| Q3 25 | 45.4% | 17.7% | ||
| Q2 25 | 16.6% | 26.8% | ||
| Q1 25 | 33.7% | 7.7% | ||
| Q4 24 | 132.1% | 26.4% | ||
| Q3 24 | 51.6% | 13.7% | ||
| Q2 24 | 18.1% | 2.1% | ||
| Q1 24 | 15.5% | — |
| Q4 25 | 5.0% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 5.6% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.5% | 0.0% |
| Q4 25 | 5.14× | — | ||
| Q3 25 | 2.38× | 1.10× | ||
| Q2 25 | 0.82× | 2.41× | ||
| Q1 25 | 4.60× | 1.21× | ||
| Q4 24 | 10.65× | — | ||
| Q3 24 | 3.12× | 0.54× | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
